Psyence Biomedical

PBM

Q4 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Overview: Psyence Biomedical(PBM) the EBIT is -1.908 M (-120.6%);the EPS is -2.64 (+84.49%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B120.64%
----
----
EPS
-2.644184.49%
----
----

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly